Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study

2017 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study​
Senni, M.; McMurray, J. J.; Wachter, R. ; McIntyre, H. F.; Anand, I. S.; Duino, V. & Sarkar, A. et al.​ (2017) 
European Journal of Heart Failure, 20(3) pp. 491​-500​.​ DOI: https://doi.org/10.1002/ejhf.1054 

Copy

Further links

Documents & Media

License

GRO License GRO License

Details

Title Variant(s)
Safety of sacubitril/valsartan in HFrEF
Authors
Senni, Michele; McMurray, John J.V.; Wachter, Rolf ; McIntyre, Hugh F.; Anand, Inder S.; Duino, Vincenzo; Sarkar, Arnab; Shi, Victor; Charney, Alan
Issue Date
2017
Journal
European Journal of Heart Failure 
ISSN
1388-9842
Language
English

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations


Social Media